HIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations [artículo]
Por: González Tomé, María Isabel [Pediatría].
Colaborador(es): Servicio de Pediatría-Neonatología.
Editor: Journal of Adolescent Health, 2011Descripción: 48(1):100-102.Recursos en línea: Solicitar documento Resumen: The use of atazanavir (ATV) in adolescents infected with human immunodeficiency virus was analyzed in this study. ATV morning plasma concentrations were determined during regular visits to the outpatient department. Results showed that bilirubin levels were higher among patients with higher ATV plasma concentrations (p = .018). Monitoring plasma levels of ATV could avoid toxicity in these patients.Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
---|---|---|---|---|
Artículo | PC5557 (Navegar estantería) | Disponible |
Formato Vancouver:
Nso Roca AP, Larru B, Bellón JM, Mellado MJ, Ramos JT, González MI, et al. HIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations. J Adolesc Health. 2011;48(1):100-2.
PMID: 21185531
Contiene 10 referencias
The use of atazanavir (ATV) in adolescents infected with human immunodeficiency virus was analyzed in this study. ATV morning plasma concentrations were determined during regular visits to the outpatient department. Results showed that bilirubin levels were higher among patients with higher ATV plasma concentrations (p = .018). Monitoring plasma levels of ATV could avoid toxicity in these patients.
No hay comentarios para este ejemplar.